TC
LRCX icon

Trilogy Capital’s Lam Research LRCX Stock Holding History

Trilogy Capital’s Portfolio LRCX Stock Details LRCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$314K Buy
+725
New +$220K 0.01% 321

Other funds holding LRCX

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

Trilogy Capital's LRCX Position: Q2 2026 in Review

Trilogy Capital opened a new position in Lam Research (LRCX) in Q2 2026: 725 shares worth $314K. The stake represents 0.01% of the portfolio and ranks #321 among its holdings.

522 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Trilogy Capital held 725 shares of Lam Research worth $314K as of Q2 2026.
  • Lam Research was a new Trilogy Capital position in Q2 2026.
  • Lam Research made up 0.01% of Trilogy Capital's portfolio in Q2 2026, its #321 holding.
  • 522 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.